Effects of theabrownin from pu-erh tea on the metabolism of serum lipids in rats: mechanism of action.
Theabrownin (TB), one of the main bioactive components in pu-erh tea, has a significant blood lipid-lowering effect in hyperlipidemic rats. Therefore, it was hypothesized that TB would regulate the activity of key enzymes involved in lipid metabolism and accelerate the catabolism of exogenous cholesterol in rats fed a high fat diet. A total of 90 Sprague-Dawley rats were randomly divided into a normal control group (Group I), a high fat diet group (Group II), and high-fat diet plus TB group (Group III). A total of 10 rats were selected from each group and killed at 15, 30, or 45 d after starting the study for analysis. After feeding 45 d, the contents of TC, TG, and LDL-C levels in Group II were increased by 54.9%, 93.1%, and 134.3% compared with those in Group III, respectively, and the content of HDL-C in Group II was decreased by 55.7%. These effects were inhibited in the rats in Group III, which exhibited no significant differences in these levels compared with Group I, indicating that TB can prevent hyperlipidemia in rats fed a high fat diet. TB enhanced the activity of hepatic lipase and hormone-sensitive triglyceride lipase (HSL) and increased the HSL mRNA expression in liver tissue and epididymis tissue. The HL activity in serum of Group III was increased by 147.6% compared with that in Group II. The content of cholesterol and bile acid in the feces of rats was increased by 21.11- and 4.08-fold by TB. It suggested that TB could promote the transformation and excretion of dietary cholesterol of rats in vivo.
Gong
Jiashun
J
Faculty of Food Science and Technology, Yunnan Agricultural Univ., Kunming, P.R.China. gong199@163.com
Peng
Chunxiu
C
Chen
Ting
T
Gao
Bin
B
Zhou
Hongjie
H
D052436:Adipose Tissue, White / Q000187:drug effects / Q000201:enzymology; D000818:Animals; D001647:Bile Acids and Salts / Q000032:analysis; D002784:Cholesterol / Q000032:analysis / Q000097:blood / Q000378:metabolism; D005243:Feces / Q000737:chemistry; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D006949:Hyperlipidemias / Q000097:blood / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D000960:Hypolipidemic Agents / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use; D007408:Intestinal Absorption / Q000187:drug effects; D008049:Lipase / Q000097:blood / Q000235:genetics / Q000378:metabolism; D050356:Lipid Metabolism / Q000187:drug effects*; D008055:Lipids / Q000032:analysis / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D008297:Male; D010860:Pigments, Biological / Q000032:analysis / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use; D010936:Plant Extracts / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D002787:Sterol Esterase / Q000235:genetics / Q000378:metabolism; D013662:Tea / Q000737:chemistry*
D001647:Bile Acids and Salts; D000960:Hypolipidemic Agents; D008055:Lipids; D010860:Pigments, Biological; D010936:Plant Extracts; D013662:Tea; D002784:Cholesterol; D002787:Sterol Esterase; D008049:Lipase; C502353:hepatic lipase, rat